Shares of Alexion Pharamaceuticals (ALXN +3.4%) register a gain after the firm says it has...

|About: Alexion Pharmaceuticals, ... (ALXN)|By:, SA News Editor

Shares of Alexion Pharamaceuticals (ALXN +3.4%) register a gain after the firm says it has received a positive opinion in Europe for Soliris with a final decision from the European Commission expected in about two months. Soliris is a first treatment for patients with a rare life-threatening blood disorder.